Not applicableStudy completedNCT01583608
What this trial is testing
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Who this might be right for
Cardiovascular DiseasesCoronary Artery DiseaseMyocardial Ischemia+7 more
Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. 183